New biomarker for common lung cancer predicts responses to ch... ( Patients with the most common type o...)

New biomarker for common lung cancer predicts responses to chemotherapy

Date:7/26/2012

Patients with the most common type of lung cancer are notoriously insensitive to chemotherapy drugs, including cisplatin. New findings related to the cellular pathways that regulate responses to cisplatin have now been published by Cell Press on July 26th in the journal Cell Reports. The findings reveal a potential biomarker that can be used to predict how these patients will respond to chemotherapy, as well as the patients' overall prognosis, paving the way for personalized treatment strategies.

Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related death in men, and it is frequently treated with cisplatin. However, responses are often brief and ineffective because cancer cells become resistant to cisplatin-induced cell death. "We were interested in finding new genes, proteins, and pathways that would govern the response to cisplatin and might explain cisplatin resistance," says senior study author Guido Kroemer of INSERMthe French National Institute of Health and Medical Research.

To identify factors that affect whether cells die in response to cisplatin, Kroemer and his team performed a genome-wide screen in which they interfered with the expression of tens of thousands of genes in cells from patients with NSCLC. They identified 85 factors that modify drug responses, including pyridoxal kinase (PDXK), an enzyme that converts vitamin B6 precursors into their active form.

Treatment with a vitamin B6 precursor enhanced the anti-tumor effects of cisplatin in mouse models of lung cancer and promoted cisplatin-induced death in a variety of cancer cell lines, but only when PDXK was present. Moreover, NSCLC patients with high expression levels of PDXK had higher survival rates than those with low levels of the enzyme, regardless of whether they were being treated with cisplatin.

Together, the findings point to PDXK as an easy-to-monitor potential biomarker for predicting both the responses of
'/>"/>

Contact: Lisa Lyons
elyons@cell.com
617-386-2121
Cell Press
Source:Eurekalert

0

GOOD

Page: 1 2
Related biology news :

1. VTT and GE Healthcare developing novel biomarkers to predict Alzheimers disease
2. Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease
3. Trial seeks improved lung-cancer screening by combining imaging and biomarkers
4. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
5. How a common fungus knows when to attack
6. Key mutations discovered for most common childhood brain cancer
7. Gut microbes battle a common set of viruses shared by global populations
8. Eating disorder behaviors and weight concerns are common in women over 50
9. Where we split from sharks: Common ancestor comes into focus
10. Common genetic mutation increases sodium retention, blood pressure
11. Children exposed to the common pollutant naphthalene show signs of chromosomal damage

Post Your Comments:

(Date:6/19/2013)... , June 19, 2013 ... clinical laboratory diagnostics technology for conducting on-demand, ... diabetes testing, as well as analysis of ... and platelet counts. The new system enables ... lab results for physicians and their patients, ...

(Date:6/19/2013)... A study of the patients who received ... rostratum from the New England Compounding Center has ... though they did not experience a worsening of ... can help detect infection, especially among those individuals ... , The study, along with an editorial by ...

(Date:6/19/2013)... AMHERST, Mass. In the cover story for the ... and colleagues at the University of Massachusetts Amherst describe ... scientists to study the function of individual proteins in ... The advance should allow deeper insights into protein function, ... understanding of what that single protein does when we ...

Breaking Biology News(10 mins):Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 2 Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 3 Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 4 Evolution of an outbreak: Complications from contaminated steroid injections 2 UMass Amherst researchers develop powerful new technique to study protein function 2 UMass Amherst researchers develop powerful new technique to study protein function 3

[0] Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies [0] Evolution of an outbreak: Complications from contaminated steroid injections [0] UMass Amherst researchers develop powerful new technique to study protein function

... , WAYNE, Pa., Dec. 14 MODA Technology Partners, ... utility and product testing for the Pharmaceutical industry, today ... third generation mobile data acquisition platform. The latest release ... regulated manufacturing processes. , MODA 3.0 includes the ...

... have resolved a question about how a popular class ... that reveal previously hidden components of chemical communication in ... the illness, people with schizophrenia also struggle to sustain ... that interfere with their ability to hold a job ...

... at The Scripps Research Institute have solved a 10-year-old ... family of enzymes can have two completely distinct roles ... understanding other molecules in the family, the research supplies ... combating diseases including cancer and macular degeneration. The ...

Cached Biology News:MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2 New biosensors reveal workings of anti-psychotic drugs in the living brain 2 Scripps Research scientists crack mystery of protein's dual function 2 Scripps Research scientists crack mystery of protein's dual function 3

MODA Announces Availability of Third Generation Mobile Data Acquisition Platform New biosensors reveal workings of anti-psychotic drugs in the living brain Scripps Research scientists crack mystery of protein's dual function

(Date:6/19/2013)... New programme aims to ... pharmaceutical and chemical sectors Pfizer Asia ... and Siemens Pte. Ltd, have signed on as ... Programme - Innovative Processing of Specialties and Pharmaceuticals ... Engineering Sciences (ICES), the consortium offers a platform ...

(Date:6/19/2013)... 2013 For an eco-friendly selection for ... Baths using metallic beads instead of water. The ... not require germicides. Yet, the bead bath delivers exceptional ... is always ready unlike a water bath, no warm-up ... bath, which eliminates the contamination and maintenance issues related ...

(Date:6/19/2013)... June 19, 2013 Bellevue city ... hall of technology solutions for people with disabilities ... Hyatt Regency Bellevue. , The exhibit hall, ... on Saturday and Sunday, will feature leading manufacturers ... wheelchairs, communication devices, eyegaze technologies, computer applications, and ...

(Date:6/19/2013)... June 19, 2013 An article posted earlier ... the increasing number of uses for probiotics. The article stated ... and the associate benefits may beeb listed, the actual ... and helping clear skin conditions. While the total uses of ... on the the uses of these “miracle” bacterium, and debunked ...

Breaking Biology Technology:Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2 Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3 Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4 Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2 City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall 2 Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2

[0] Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences [0] Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths [0] City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall [0] Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health

... BARCELONA, February 26 Prous Institute for Biomedical,Research ... its newly,designed website ( http://www.prousresearch.com ). A large ... coverage is being,developed at Prous Institute under the ... President and C.E.O. of the Institute, Dr. ...

... Insmed Inc. (Nasdaq: INSM ), a developer ... conference call on Wednesday, March 11th at 8:30 AM ... quarter and year-end 2008. Insmed intends to issue ... on March 11th.To participate in the live conference call, ...

... 26 NicOx,S.A. (NYSE Euronext Paris: COX) today ... provided an overview of the development and,pre-commercialization activities ... of the signs and symptoms of osteoarthritis (OA). ... Executive Officer of NicOx, commented: "We believe,NicOx has ...

Prous Institute Presents Innovative Approach to Drug Discovery Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value

...

... clone 41D GenBank Accession Number ... clusterin purified from human serum Formulation: ... and 0.05% sodium azide Quality Assurance: ... HeLa cells or MCF-7 cell lysates. ...

Anti-CoralHue Dronpa Green Monoclonal Antibody Research Focus: cell surface antigens Storage: -20C Shipping Temperature: +4C...

Sheep polyclonal to Methaqualone ( Abpromise for all tested applications). Antigen: Methaqualone(5') conjugated to BSA...

Biology Products:

ThermoTWISTER comfort from QUANTIFOIL Instruments Mouse Anti-Human Clusterin alpha chain Monoclonal Antibody, Unconjugated, Clone 41D from Upstate Mouse Anti-Dronpa Green CoralHue Monoclonal Antibody, Unconjugated, Clone 2F6 from MBL International Sheep Anti-Methaqualone Polyclonal Antibody, Unconjugated from Abcam